Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Prof Rod Baber
Menopausal Hormone Therapy - What Dose of Estrogen is Best?
Dr Adam Nelson
Cardiovascular Benefits of GLP1s – New Evidence
Dr Kathleen McNamee, Prof Sonia Grover
Oral Contraceptive Pill in Teens
Prof Andrew Sindone
RSV and the Heart
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
